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A B S T R A C T
Core-shell nanofibers were designed via electrospinning using inclusion complex (IC) of model
hydrophobic drug (curcumin, CUR) with cyclodextrin (CD) in the core and polymer (polylactic acid, PLA)
in the shell (cCUR/HPbCD-IC-sPLA-NF). CD-IC of CUR and HPbCD was formed at 1:2 molar ratio. The
successful formation of core-shell nanofibers was revealed by TEM and CLSM images. cCUR/HPbCD-IC-
sPLA-NF released CUR slowly but much more in total than PLA-CUR-NF at pH 1 and pH 7.4 due to the
restriction of CUR in the core of nanofibers and solubility improvement shown in phase solubility
diagram, respectively. Improved antioxidant activity of cCUR/HPbCD-IC-sPLA-NF in methanol:water
(1:1) is related with the solubility enhancement achieved in water based system. The slow reaction of
cCUR/HPbCD-IC-sPLA-NF in methanol is associated with the shell inhibiting the quick release of CUR. On
the other hand, cCUR/HPbCD-IC-sPLA-NF exhibited slightly higher rate of antioxidant activity than PLA-
CUR-NF in methanol:water (1:1) owing to the enhanced solubility. To conclude, slow release of CUR was
achieved by core-shell nanofiber structure and inclusion complexation of CUR with HPbCD provides high
solubility. Briefly, electrospinning of core-shell nanofibers with CD-IC core could offer slow release of
drugs as well as solubility enhancement for hydrophobic drugs.
© 2017 Elsevier B.V. All rights reserved.
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Curcumin (CUR) (Fig. 1a) is a polyphenol and apart from its
usage as a therapeutic agent, it is widely employed as a spice, food
preservative, flavoring and coloring agent (Aggarwal et al., 2003).
Its common application for various diseases including cancer,
cardiovascular and Alzheimer’s disease, inflammatory and neuro-
logical disorders is owing to the outstanding biological functions
such as antioxidant, anti-tumor, and anti-inflammatory activities
of CUR (Yallapu et al., 2015). But, it also exhibits drawbacks like low
bioavailability, instability depending on pH, insolubility in water,
slow uptake by the cells and rapid metabolism inside the cell
(Siviero et al., 2015). Several strategies were developed previously
to improve pharmacokinetics, systemic bioavailability, and biolog-
ical activity of CUR (Siviero et al., 2015). Among these strategies,
cyclodextrin (CD) inclusion complexes (ICs) is a commonly applied
method to overcome the limitations of CUR. CDs are nontoxic and
biodegradable cyclic oligosaccharides which are capable of* Corresponding author at: Institute of Materials Science & Nanotechnology,
Bilkent University, Ankara 06800, Turkey.
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0378-5173/© 2017 Elsevier B.V. All rights reserved.forming ICs with a variety of molecules to enhance solubility,
bioavailability, and thermal stability of hydrophobic guest com-
pounds; reduce the volatility of molecules with low thermal
stability, mask off malodors/bitter tastes, and control release of
active agents (Del Valle, 2004; Hedges 1998; Szejtli, 1998). The
most common CDs are a-CD, b-CD and g-CD with 6, 7, and 8
glucose units, respectively. In addition, chemically modified CDs
including hydroxypropyl-beta-cyclodextrin (HPbCD) (Fig. 1b) in
which some of the hydroxyl groups in the b-CD structure are
substituted with hydroxypropyl groups were also synthesized.
HPbCD is more suitable for the solubilization of hydrophobic drugs
due to its better aqueous solubility compared to native b-CD (Del
Valle, 2004; Hedges 1998; Szejtli,1998). IC of CUR and HPbCD were
studied before for several aims such as enhancing the solubility
and fluorescence (Baglole et al., 2005), oral bioavailability (Bansal
et al., 2011) of CUR; treating melanoma (Sun et al., 2014), and
inflammatory bowel disease (Yadav et al., 2009).
Nanofibers are quite appropriate to carry active agents
including drugs, antioxidant, and antibacterial agents owing to
high surface to volume ratio and porous structure (Agarwal et al.,
2008). Furthermore, owing to the morphological similarities of
nanofibers with extracellular matrix, biomaterials for wound
healing and scaffolds for tissue engineering could be developed by
Fig. 1. (a) Chemical structure of CUR, (b) chemical structure and schematic representation of HPbCD; schematic representation of (c) formation of CUR/HPbCD-IC, and (d)
electrospinning of core-shell nanofibers from cCUR/HPbCD-IC-sPLA solution.
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2012). Recently, there has been significant interest on electro-
spinning which is a simple and common technique for producing
nanofibers (Greiner and Wendorff, 2007; Wendorff et al., 2012).
Design flexibility of electrospun nanofibers facilitates the encap-
sulation of active agents for biomedical applications (Greiner and
Wendorff, 2007; Wendorff et al., 2012). CUR loaded electrospun
nanofibers were reported previously in the literature (Guo et al.,
2011; Sampath et al., 2014; Suwantong et al., 2007). However,
rather than loading free active agents into electrospun nanofibers,
incorporating their CD-ICs is advantageous in many aspects as
previously reported in the studies of our group. For instance,
volatile molecules were highly preserved (Aytac et al., 2014; Kayaci
et al., 2013a, 2014; Kayaci and Uyar, 2012; Uyar et al., 2009a, 2009b,
2011) and the solubility of hydrophobic molecules were improved
(Aytac et al., 2015, 2016a, 2016b; Aytac and Uyar, 2016; Kayaci et al.,
2013b) by CD-IC incorporated nanofibers. Sun et al. (2013)
published a study concerning CUR/CD-IC loaded electrospun
nanofibers (Sun et al., 2013). Faster release was seen from CUR/
HPbCD-IC incorporated polyvinyl alcohol (PVA) nanofibers than
CUR incorporated PVA nanofibers owing to the solubility
enhancement and it is expected for CUR/HPbCD-IC incorporated
PVA nanofibers to exhibit higher systemic bioavailability and
enhanced in vivo efficacy. On the other hand, it is of great
importance for some compounds to be protected against organic
solvents, encapsulated in large amount and released in a more
controlled manner. Due to the flexibility of the set-up, nanofibers
with different morphologies such as core-shell, aligned and hollow
nanofibers can be obtained via electrospinning (Ramakrishna et al.,
2005). Particularly, electrospinning of core-shell nanofibers has
several advantages such as possibility to electrospun nanofibers
from non-spinnable solutions (Sun et al., 2003), protecting
sensitive active agents against harsh environment of organic
solvents (Jiang et al., 2014), controlling the release of active agents
in a more efficient way due to the presence of shell acting as an
additional layer (Jiang et al., 2005), encapsulating more than one
drug at the same time (Llorens et al., 2015), designing active agent
containing nanofibers for targeted release (Wang et al., 2015). In
the study of Llorens et al. (2015), triclosan loaded poly(ethylene
glycol) and CUR loaded poly(butylene succinate) solutions were
used as core or shell solutions at different compositions. The
release of triclosan and CUR were investigated in PBS and PBS/
ethanol (30:70, v/v). CUR could not be released in PBS from allcompositions because of its high hydrophobicity and interaction
with poly(butylene succinate); whereas it was completely released
in PBS/ethanol (30:70, v/v) (Llorens et al., 2015). Kumar et al.
(2014) produced core-shell nanofibers by encapsulating CUR and
5-fluorouracil in the core and then, both core and shell polymers
was crosslinked in type I nanofibers; whereas only shell was
crosslinked in type II nanofibers. But, crosslinking of core and shell
or only shell did not affect the release rate and amount of CUR in
contrast to 5-fluorouracil (Kumar et al., 2014). In the study of
Sedghi and Shaabani (2016) core-shell polymer-free core structure
nanofibers was produced by using CUR solution in the core and
PVA and chitosan in the shell. Although the burst release of CUR
was prevented by core-shell nanofibers compared to blend
nanofibers, core-shell nanofibers released less amount of CUR
than blend nanofibers due to the low solubility of CUR in aqueous
solutions (Sedghi and Shaabani, 2016).
In this study, core-shell nanofibers of CUR/HPbCD-IC (as a core)
(Fig. 1c) and polylactic acid (PLA) (as a shell) which is an aliphatic
polyester and widely used in biological applications due to its
biodegradability and biocompatibility was produced via electro-
spinning (cCUR/HPbCD-IC-sPLA-NF) (Fig. 1d). As a control sample,
CUR blended with PLA was also electrospun into nanofibers (PLA-
CUR-NF). The molar ratio of the CUR:HPbCD inclusion complex
was 1:2 and the phase solubility test confirmed the water solubility
increase of CUR with the inclusion complexation. Core-shell
morphology of cCUR/HPbCD-IC-sPLA-NF was confirmed by TEM
and CLSM imaging. In vitro release of CUR from PLA-CUR-NF and
cCUR/HPbCD-IC-sPLA-NF was tested in 0.1 N HCl (pH 1), PBS (pH
7.4), methanol, and methanol:water (1:1). The antioxidant activity
of nanofibers was investigated by 2,2-diphenyl-1-picrylhydrazyl




Polylactic acid (PLA) (Natureworks, product code 6252D) and
hydroxypropyl-beta-cyclodextrin (HPbCD) (Wacker Chemie AG,
Germany) was donated to our research group for laboratory
studies. Curcumin (CUR, 95%, Alfa Aesar), zinc acetate dehydrate
(Sigma Aldrich), fluorescein isothiocyanate (FITC, Sigma Aldrich),
potassium phosphate monobasic (Sigma Aldrich), sodium
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(Sigma Aldrich), methanol (extra pure, Sigma Aldrich), chloroform
(CHCl3, extra pure, Sigma Aldrich), deuterated dimethylsulfoxide
(DMSO-d6, deuteration degree min 99.8% for NMR spectroscopy,
Merck), hydrochloric acid (HCl, 36.5–38%, Sigma-Riedel), 2,2-
diphenyl-1-picrylhydrazyl (DPPH, Sigma Aldrich) were purchased
and used as-received without any further purification. Distilled-
deionized water was supplied from Millipore milli-Q ultrapure
water system.
2.2. Preparation of solutions for electrospinning
Core-shell nanofibers of CUR/HPbCD-inclusion complex (CUR/
HPbCD-IC) as a core and PLA as a shell were produced via
electrospinning (cCUR/HPbCD-IC-sPLA-NF). As control samples,
pristine PLA nanofibers (PLA-NF) and CUR blended with PLA was
also electrospun (PLA-CUR-NF). PLA solution was prepared by
dissolving PLA (15%, w/v) in CHCl3:Methanol (2:1) for 3 h. In order
to produce PLA-CUR-NF, PLA-CUR solution was prepared by
dissolving 3.33% CUR (w/w, with respect to polymer) in CHCl3:
Methanol (2:1), then PLA (15%, w/v) was added into the solution.
The solution was stirred at room temperature (RT) for 3 h prior to
electrospinning. For core-shell nanofibers, core solution was
prepared by dissolving HPbCD in water and then adding CUR
(CUR:HPbCD, 1:2 molar ratio) and the core solution was stirred
overnight at RT. In addition, PLA (15%, w/v) was dissolved in CHCl3:
Methanol (2:1) for 3 h at RT to be used as shell solution. The
compositions of the solutions used for the electrospinning of
nanofibers are summarized in Table S1.
2.3. Electrospinning
PLA-NF and PLA-CUR-NF was produced by single-nozzle
electrospinning. PLA and PLA-CUR solutions were loaded sepa-
rately in a plastic syringe (inner diameter: 0.8 mm) and mounted
on a syringe pump (WPI, SP 101IZ). Then, the solutions were fed at
a rate of 1 mL/h and meanwhile 15 kV was applied from a high
voltage power supply (AU Series, Matsusada Precision Inc.).
Nanofibers were deposited on a grounded cylindrical metal
covered with aluminum foil at a distance of 10 cm from the
needle tip. In order to electrospun cCUR/HPbCD-IC-sPLA-NF,
home-made core-shell setup was used (Fig. 1d). Core and shell
solutions were loaded in plastic syringes mounted on two syringe
pumps. The core solution sent at a rate of 1 mL/h, whereas the shell
solution was sent at a rate of 3 mL/h towards to collector. The
electrospinning of the nanofibers was performed at 25 C under
18–20% relative humidity.
2.4. Characterizations and measurements
Phase solubility study was performed in aqueous solution
according to the previously described method (Higuchi and
Connors, 1965). Excess amount of CUR was added into the
solutions containing varying amount of HPbCD (0–20 mM). The
suspensions were stirred overnight at RT and spectrophotometric
determination was done at 425 nm (Varian, Cary 100) after the
filtration of the solutions. The measurements were carried out in
triplicate and the phase diagram was drawn by plotting the molar
concentration of CUR against the molar concentration of HPbCD
according to the calibration curve.
CUR/HPbCD-IC was formed according to the co-precipitation
method at 1:2 molar ratio (CUR:HPbCD) and the final molar ratio
of CUR/HPbCD-IC was confirmed by proton nuclear magnetic
resonance (1H NMR) measurement. First of all, HPbCD was
dissolved in aqueous solution; then CUR was added and the
solution was stirred for 12 h at RT. Finally, the solution was filtratedafter keeping it in refrigerator for 6 h and dried in hood for 2 days.
1H NMR spectra of CUR, HPbCD, and CUR/HPbCD-IC dissolved in
DMSO-d6 were taken on Bruker DPX-400. The assignment of
protons of CUR and HPbCD are depicted in Fig. S1. Then, the molar
ratio of CUR and HPbCD in CUR/HPbCD-IC was calculated by using
the integration of the chemical shifts (d) given in parts per million
(ppm) calculated via Mestrenova software.
The morphological characterization of cCUR/HPbCD-IC-sPLA-
NF was performed by transmission electron microscopy (TEM,
Tecnai G2 F30), confocal laser scanning microscopy (CLSM, Zeiss
LSM 510), and scanning electron microscopy (SEM, FEI – Quanta
200 FEG). The SEM imaging of PLA-CUR-NF as a control sample was
also performed. The nanofiber samples were sputtered with 5 nm
of Au/Pd (PECS-682) to avoid charging problem during SEM
imaging. The calculation of average fiber diameter (AFD) of the
nanofibers was made on SEM images (n  100) and the results are
given as average  standard deviation. For the proof of core-shell
morphology of cCUR/HPbCD-IC-sPLA-NF, zinc acetate dehydrate
was added to the core solution (CUR/HPbCD-IC) and core-shell
nanofibers were collected on TEM grids. For CLSM imaging, FITC
was added to the core solution (CUR/HPbCD-IC) and nanofibers
were collected on glass slides.
X-ray diffraction (XRD) was employed to investigate the
crystalline structure of CUR (powder), HPbCD (powder), PLA-NF,
and cCUR/HPbCD-IC-sPLA-NF. XRD data were recorded using a
PANalytical X’Pert powder diffractometer applying Cu K radiation
in the 2 theta range of 5–30.
Thermal properties of CUR (powder), HPbCD (powder), PLA-NF,
PLA-CUR-NF, and cCUR/HPbCD-IC-sPLA-NF were examined by
thermal gravimetric analysis (TGA, TA Q500, USA). The samples
were heated up to 500 C at a constant heating rate of 20 C/min
under nitrogen atmosphere for TGA measurement.
Nanofibers having equivalent amount of CUR was immersed in
25 mL of 0.1 M HCl (pH 1), PBS (pH 7.4), methanol and methanol:
water (1:1) at RT for 120, 480, 60, and 600 min, respectively. The
cumulative amount of CUR released from PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF was investigated via UV spectroscopy for 0.1 M
HCl (pH 1) and PBS (pH 7.4) and high performance liquid
chromatography (HPLC, Agilient, 1200 series) equipped with
VWD UV detector (425 nm) for methanol and methanol:water
(1:1). 0.5 mL of solution was withdrawn at predetermined time
intervals and an equal amount of fresh medium was refilled for
HPLC measurement. The separation was accomplished by C18
column (Inertisil, column dimension: 4.6 mm 50 mm, particle size:
5 mm) operating at 1 mL/min using methanol as an eluent. The
calibration curves were obtained to convert absorbance and area
values obtained from UV spectroscopy and HPLC to concentration
(ppm). The experiments were performed in triplicate and the
results were reported as average  standard deviation. The
morphology of nanofibers was also evaluated after immersion of
nanofibers into 0.1 M HCl (pH 1) and PBS (pH 7.4).
According to 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical
scavenging assay, antioxidant activity of PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF were tested depending on concentration and
time. Concentration dependent antioxidant activity tests were
done by immersing nanofibers having equivalent amount of CUR in
methanol (for 60 min) and methanol:water (1:1) (for 600 min) as
decided from release tests. The dilution of the solutions were done
in methanol and methanol:water (1:1), respectively. Then, 1 mL of
those solutions were mixed with 2 mL of 104 DPPH prepared in
methanol. After incubation of the solutions in dark at RT for 60 min,
absorbance of the solutions was determined by UV spectroscopy
(Varian, Cary 100) at 517 nm. In order to calculate antioxidant
activity (%), the absorbance of DPPH was defined as 100% and the
antioxidant activity (%) was calculated based on the following
equation:
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where Acontrol and Asample represent the absorbance values of
control DPPH solution and DPPH solution with nanofibers,
respectively. Efficient concentration (EC50) was defined as the
amount of antioxidant molecule necessary to decrease DPPH
concentration by 50% (Brand-Williams et al., 1995). For time
dependent tests, nanofibers with equivalent amount of CUR were
immersed in methanol (for 60 min) and methanol:water (1:1) (for
600 min) and 1 mL of those solutions were mixed with 2 mL of 104
DPPH prepared in methanol. Then, the mixtures were incubated in
dark at RT for 60 min. The absorbance of the solutions was
measured by UV spectroscopy at 517 nm.
3. Results and discussion
3.1. Phase solubility studies
Phase solubility diagram for CUR:HPbCD system is shown in
Fig. 2. The inset photographs given in Fig. 2 presented the change of
transparent color of the solution to yellow as the concentration of
dissolved CUR increased. Solubility study was performed with
increasing amount of CD in aqueous solution at RT. The solubility of
CUR enhanced linearly up to 16 mM of HPbCD, beyond that point
the curve deviates in a positive direction from linearity. So, the
solubility curve of CUR:HPbCD system is classified as Ap type
(Brewster and Loftsson, 2007; Takahashi et al., 2012). Ap type phase
solubility diagram suggests the formation of higher order
complexes with respect to CD at higher concentration of HPbCD
(CUR:HPbCD, 1:>1) as well (Brewster and Loftsson, 2007;
Takahashi et al., 2012). Therefore, this result is in agreement with
the initially used molar ratio which is 1:2 (CUR:HPbCD) and this is
also confirmed with the proton nuclear magnetic resonance (1H
NMR) result as discussed in detail below.
3.2. The molar ratio of inclusion complex
The molar ratio of 1:2 (CUR:HPbCD) was used for the
preparation of inclusion complex between the guest molecule
(CUR) and the host molecule (HPbCD). Once the CUR/HPbCD-IC is
formed, we checked the true molar ratio of CUR:HPbCD in the
sample by 1H NMR (Fig. S1 in Supplementary material). For the
analyses, CUR, HPbCD, and CUR/HPbCD-IC was dissolved in
DMSO-d6 and then 1H NMR spectra were recorded. The assign-
ment of protons of CUR and HPbCD are depicted in Fig. S1 in
Supplementary material. The molar ratio of CUR to HPbCD was
calculated as 1:2 by taking the integration of CUR peak at 6 ppm
and HPbCD peak at 1 ppm. Therefore, it was concluded that theFig. 2. Phase solubility diagram of CUR/HPbCD system in water. Inset photographs
show the change of the solution color with increasing HPbCD concentration (0–
20 mM). initial amount of CUR and HPbCD (1:2) was preserved perfectly
after the inclusion complexation process.
3.3. Morphology analyses of nanofibers
Transmission electron microscopy (TEM) and confocal laser
scanning microscopy (CLSM) images of cCUR/HPbCD-IC-sPLA-NF
are shown in Fig. 3a and 3b. Both of the images confirmed the core-
shell structure of nanofibers. The morphology of PLA-CUR-NF and
cCUR/HPbCD-IC-sPLA-NF was further examined by scanning
electron microscopy (SEM) Fig. 4a-b. AFD of nanofibers were
determined as 780  375 nm and 695  280 nm, respectively. As
seen from the photographs given in Fig. 4c–d, both of the
nanofibers have yellow color but the shade of the nanofibers is
obviously different from each other. The reason of the pale yellow
color of cCUR/HPbCD-IC-sPLA-NF is because the CUR/HPbCD-IC is
covered with the PLA layer as a shell in this sample.
3.4. Crystalline structure of the nanofibers
The crystalline structure of CUR, HPbCD, PLA-NF, and cCUR/
HPbCD-IC-sPLA-NF were investigated via X-ray diffraction (XRD)
(Fig. S2). CUR is a crystalline molecule, whereas HPbCD is
amorphous molecule as seen from the diffraction patterns. As
seen from the diffraction pattern, cCUR/HPbCD-IC-sPLA-NF did not
show crystalline peaks of CUR. The CUR/HPbCD-IC is loaded in the
fiber matrix as a core and it is expected that CUR would preserve its
crystalline phase if there is no true inclusion complexation with
the HPbCD. It is well known that once inclusion complex is formed,
guest molecules are separated from each other by the cavity of the
CD molecule and therefore cannot form crystals (Giordano et al.,
2001). Here, the absence of crystalline peaks of CUR for cCUR/
HPbCD-IC-sPLA-NF sample suggested that the true inclusion
complexation between CUR and HPbCD was preserved even after
the electrospinning process.
3.5. Thermal analyses of nanofibers
Thermal gravimetric analysis (TGA) of CUR, HPbCD, PLA-NF,
PLA-CUR-NF, and cCUR/HPbCD-IC-sPLA-NF are given in Fig. S3. The
thermal degradation of CUR started at around 200 C. Native
HPbCD exhibited its main degradation with a weight loss in the
temperature range from 290 C to 425 C. The weight loss of PLA-
NF is observed between 200 C and 375 C and corresponds to the
degradation of PLA. The weight loss in TGA thermograms of PLA-
CUR-NF and cCUR/HPbCD-IC-sPLA-NF is seen between 215–375 C
and 215–425 C, respectively. So, the thermal stability of CUR
slightly improved in PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-NF.
Because of the overlapping in the thermal degradation of CUR, PLA,
and HPbCD, the amount of CUR in nanofibers could not be
determined from TGA data.Fig. 3. (a) TEM and (b) CLSM image of cCUR/HPbCD-IC-sPLA-NF.
Fig. 4. SEM image of electrospun nanofibers obtained from the solutions of (a) PLA-CUR and (b) cCUR/HPbCD-IC-sPLA; the photographs of (c) PLA-CUR-NF and (d) cCUR/
HPbCD-IC-sPLA-NF.
Fig. 5. The cumulative release of CUR from PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-
NF into (a) pH 1 and (b) pH 7.4 (n = 3). The error bars in the figure represent the
standard deviation (SD).
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The pH dependent release of CUR from PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF were investigated in 0.1 M HCl (pH 1,
simulated gastric fluid) and PBS (pH 7.4, simulated intestinal
fluid) at RT (Fig. 5a–b). Higher amount of CUR released from both of
the nanofibers at pH 1 compared to pH 7.4. Since CUR is known to
exist in cationic, neutral or anionic forms depending on pH and
these forms influence the solubility of CUR. Hence, when pH is
acidic, CUR releases readily from the nanofibers due to increased
solubility when it is in cationic form (Massaro et al., 2016).
Moreover, the rate of release from cCUR/HPbCD-IC-sPLA-NF was
slower compared to PLA-CUR-NF at the initial step at both pH 1 and
pH 7.4 owing to shell structure in cCUR/HPbCD-IC-sPLA-NF. On the
other hand, CUR released from cCUR/HPbCD-IC-sPLA-NF was
much more in total than PLA-CUR-NF at pH 1 and pH 7.4 most
probably due to the solubility enhancement of CUR by HPbCD
inclusion complexation as shown in Fig. 2. After in vitro release
test, possibility of fiber matrix degradation was investigated by the
morphology change in SEM images (Fig. S4 in Supplementary
material). If nanofiber matrix undergoes degradation overtime,
erosion based release mechanism is anticipated. However, SEM
images clearly showed that PLA-CUR-NF and cCUR/HPbCD-IC-
sPLA-NF samples preserved their fibrous structure during the
release period, and therefore, in our case the release mechanism is
diffusion based.
The release of CUR was evaluated in methanol and methanol:
water (1:1) as well (Fig. 6a–b). PLA-CUR-NF released much more
CUR in methanol; whereas cCUR/HPbCD-IC-sPLA-NF released
slightly more amount of CUR in methanol:water (1:1) comparative
to its counterpart. This is likely due to the high solubility of CUR in
methanol when it is in free form and enhanced water solubility of
CUR in methanol:water (1:1) when it is formed an IC with HPbCD.
Fig. 6. The cumulative release of CUR from PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-NF into (a) methanol and (b) methanol:water (1:1) (n = 3). The error bars in the figure
represent the standard deviation (SD).
Fig. 7. (a) Concentration dependent antioxidant activity of PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF (methanol), (b) the photographs of the solutions with respect to
concentration; (c) time dependent antioxidant activity of PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF (methanol).
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The reduction of chronic diseases, DNA damage, mutagenesis,
carcinogenesis, and inhibition pathogenic bacterial growth is
mostly related with the free radical scavenging ability of
antioxidant compounds (Ak and Gulcin, 2008). Antioxidant
activity of molecules is often due to the presence of the phenolic
hydrogen in their structure, but since CUR’s phenolic hydrogen
atoms are intramolecularly hydrogen-bonded to the methoxy
groups, hydrogen abstraction from phenolic ring of CUR is difficult
(Gulcin, 2012). However, abstraction of hydrogen from the carbon
atom which is in the heptadienone linkage between the two
methoxyphenol rings is relatively easier and this abstraction is the
main reason of antioxidant activity of CUR (Gulcin, 2012).
Antioxidant activity of PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-
NF was tested by 2,2-diphenyl-1-picrylhydrazyl (DPPH) with
respect to concentration and time firstly by extracting CUR from
nanofibers in methanol or methanol:water (1:1) (Figs. 7 and 8). For
methanol, PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-NF has 44  2–
95  0% and 34 1–94  3% antioxidant activity in the concentra-
tion range of 5–160 ppm, respectively (Fig. 7a). According to
concentration dependent test made in methanol, efficient concen-
tration 50 (EC50) was determined between 5 and 10 ppm and 20–
40 ppm for PLA-CUR-NF and cCUR/HPbCD-IC-sPLA-NF, respective-
ly. Lower EC50 shows higher free radical scavenging capability of
PLA-CUR-NF. This result is also consistent with the release study
made in methanol in which PLA-CUR-NF released higher amount of
CUR compared to cCUR/HPbCD-IC-sPLA-NF. The visual investiga-
tion of the resulting solutions also shows the coherence with the
calculated antioxidant activities (Fig. 7b). For instance, cCUR/
HPbCD-IC-sPLA-NF exhibited 34 1% of antioxidant activity and
the color of the solution was purple; when 94  3% of antioxidant
activity was seen, the color of the solution became yellow.
Time dependent antioxidant activity of nanofibers from which
methanol was used to extract CUR was evaluated for 60 min
(Fig. 7c). PLA-CUR-NF has reached its maximum antioxidant
activity in 2 min (93  1%); whereas cCUR/HPbCD-IC-sPLA-NF
shows its maximum antioxidant activity (84  3%) in 15 min. The
slow antioxidant activity of cCUR/HPbCD-IC-sPLA-NF as comparedto PLA-CUR-NF is due to the presence of an additional hydrophobic
barrier (shell) delaying the access of water and dissolution of CUR.
The antioxidant activity of PLA-CUR-NF and cCUR/HPbCD-IC-
sPLA-NF extracted using methanol:water (1:1) was calculated as
44  3–89  1% and 39  1–92  3% in the range of 5–160 ppm,
Fig. 8. (a) Concentration dependent antioxidant activity of PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF (methanol:water, 1:1), (b) the photographs of the solutions
with respect to concentration; (c) time dependent antioxidant activity of PLA-CUR-
NF and cCUR/HPbCD-IC-sPLA-NF (methanol:water, 1:1).
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HPbCD-IC-sPLA-NF was decided to be slightly higher than 20 ppm.
So, cCUR/HPbCD-IC-sPLA-NF exhibited quite similar antioxidant
capability with PLA-CUR-NF. This result is compatible with the
release study; thus, when the solubility of CUR was enhanced by
complexation, cCUR/HPbCD-IC-sPLA-NF exhibited antioxidant
activity quite well. The photographs of each solution show the
change of purple to yellow color with the increasing concentration
of CUR (Fig. 8b).
Time dependent antioxidant activity of PLA-CUR-NF and cCUR/
HPbCD-IC-sPLA-NF was measured for 60 min and antioxidant
activities were decided as 78  2% and 87  2% for PLA-CUR-NF and
whereas cCUR/HPbCD-IC-sPLA-NF, respectively (Fig. 8c). The
maximum antioxidant activity of PLA-CUR-NF and cCUR/HPbCD-
IC-sPLA-NF were obtained in 15 min (74  2%) and 8 min (81 4%),
respectively. This result indicated relatively quick antioxidant
activity of cCUR/HPbCD-IC-sPLA-NF in methanol:water (1:1) in
comparison with methanol owing to the greater solubility of CUR
in water based system.
4. Conclusions
Core-shell nanofibers were produced using cyclodextrin-
inclusion complex (CD-IC) of a model hydrophobic drug (curcumin,
CUR) in the core and polylactic acid (PLA) in the shell (cCUR/
HPbCD-IC-sPLA-NF) by electrospinning. CUR released from cCUR/
HPbCD-IC-sPLA-NF was much more than PLA-CUR-NF at pH 1 and
pH 7.4 most probably due to the solubility enhancement as shown
in phase solubility diagram. In addition, due to the presence of a
shell layer CUR released slower from cCUR/HPbCD-IC-sPLA-NF as
compared to PLA-CUR-NF. Efficient concentration 50 (EC50) waslower for cCUR/HPbCD-IC-sPLA-NF in methanol:water than in
methanol since inclusion complexation of CUR and HPbCD
improves the solubility of CUR in aqueous solution. The relatively
slow antioxidant activity of cCUR/HPbCD-IC-sPLA-NF in methanol
is likely due to the additional polymeric barrier (shell) delaying the
access of water; whereas slightly quick antioxidant activity is
associated with the high solubility of CUR/HPbCD-IC in methanol:
water (1:1). In short, drug delivery systems based on core-shell
nanofiber structure in which hydrophobic drugs are placed in the
core structure in the form of inclusion complex with cyclodextrins
could provide slow release as well as high water solubility for such
hydrophobic drugs.
Acknowledgements
This work was supported by The Scientific and Technological
Research Council of Turkey (TUBITAK)-Turkey (Project # 111M459).
Dr. Uyar also acknowledges The Turkish Academy of Sciences-
Outstanding Young Scientists Award Program (TUBA-GEBIP)-
Turkey for the partial support. Z. Aytac thanks to TUBITAK-BIDEB
(2211-C) and TUBITAK (project # 111M459) for the PhD scholar-
ship. We express our special thanks to Dr. Anitha Senthamizhan for
her help in the confocal laser scanning microscopy imaging.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.
ijpharm.2016.12.061.
References
Agarwal, S., Wendorff, J.H., Greiner, A., 2008. Use of electrospinning technique for
biomedical applications. Polymer 49 (26), 5603–5621.
Aggarwal, B.B., Kumar, A., Bharti, A.C., 2003. Anticancer potential of curcumin:
preclinical and clinical studies. Anticancer Res. 23 (1A), 363–398.
Ak, T., Gulcin, I., 2008. Antioxidant and radical scavenging properties of curcumin.
Chem. Biol. Interact. 174 (1), 27–37.
Aytac, Z., Uyar, T., 2016. Antioxidant activity and photostability of a-tocopherol/
b-cyclodextrin inclusion complex encapsulated electrospun polycaprolactone
nanofibers. Eur. Polym. J. 79, 140–149.
Aytac, Z., Dogan, S.Y., Tekinay, T., Uyar, T., 2014. Release and antibacterial activity of
allyl isothiocyanate/b-cyclodextrin complex encapsulated in electrospun
nanofibers. Colloids Surf. B: Biointerfaces 120, 125–131.
Aytac, Z., Sen, H.S., Durgun, E., Uyar, T., 2015. Sulfisoxazole/cyclodextrin inclusion
complex incorporated in electrospun hydroxypropyl cellulose nanofibers as
drug delivery system. Colloids Surf. B: Biointerfaces 128, 331–338.
Aytac, Z., Kusku, S.I., Durgun, E., Uyar, T., 2016a. Encapsulation of gallic acid/
cyclodextrin inclusion complex in electrospun polylactic acid nanofibers:
release behavior and antioxidant activity of gallic acid. Mater. Sci. Eng. C 63,
231–239.
Aytac, Z., Kusku, S.I., Durgun, E., Uyar, T., 2016b. Quercetin/b-cyclodextrin inclusion
complex embedded nanofibres: slow release and high solubility. Food Chem.
197, 864–871.
Baglole, K.N., Boland, P.G., Wagner, B.D., 2005. Fluorescence enhancement of
curcumin upon inclusion into parent and modified cyclodextrins. J. Photochem.
Photobiol. A: Chem. 173 (3), 230–237.
Bansal, S.S., Kausar, H., Aqil, F., Jeyabalan, J., Vadhanam, M.V., Gupta, R.C., Ravoori, S.,
2011. Curcumin implants for continuous systemic delivery: safety and
biocompatibility. Drug Deliv. Transl. Res. 1 (4), 332–341.
Brand-Williams, W., Cuvelier, M.E., Berset, C.L.W.T., 1995. Use of a free radical
method to evaluate antioxidant activity. LWT-Food Sci. Technol. 28 (1), 25–30.
Brewster, M.E., Loftsson, T., 2007. Cyclodextrins as pharmaceutical solubilizers. Adv.
Drug Deliv. Rev. 59 (7), 645–666.
Del Valle, E.M., 2004. Cyclodextrins and their uses: a review. Process Biochem. 39
(9), 1033–1046.
Giordano, F., Novak, C., Moyano, J.R., 2001. Thermal analysis of cyclodextrins and
their inclusion compounds. Thermochim. Acta 380 (2), 123–151.
Greiner, A., Wendorff, J.H., 2007. Electrospinning: a fascinating method for the
preparation of ultrathin fibers. Angew. Chem. Int. Ed. 46 (30), 5670–5703.
Gulcin, I., 2012. Antioxidant activity of food constituents: an overview. Arch. Toxicol.
86 (3), 345–391.
Guo, G., Fu, S., Zhou, L., Liang, H., Fan, M., Luo, F., Qian, Z., Wei, Y., 2011. Preparation of
curcumin loaded poly (e-caprolactone)-poly (ethylene glycol)-poly
(e-caprolactone) nanofibers and their in vitro antitumor activity against Glioma
9L cells. Nanoscale 3 (9), 3825–3832.
184 Z. Aytac, T. Uyar / International Journal of Pharmaceutics 518 (2017) 177–184Hedges, A.R.,1998. Industrial applications of cyclodextrins. Chem. Rev. 98 (5), 2035–
2044.
Higuchi, T.K., Connors, A., 1965. Phase-solubility techniques. Adv. Anal. Chem.
Instrum. 4, 117–212.
Jiang, H., Hu, Y., Li, Y., Zhao, P., Zhu, K., Chen, W., 2005. A facile technique to prepare
biodegradable coaxial electrospun nanofibers for controlled release of bioactive
agents. J. Control. Release 108 (2), 237–243.
Jiang, H., Wang, L., Zhu, K., 2014. Coaxial electrospinning for encapsulation and
controlled release of fragile water-soluble bioactive agents. J. Control. Release
193, 296–303.
Kayaci, F., Uyar, T., 2012. Encapsulation of vanillin/cyclodextrin inclusion complex in
electrospun polyvinyl alcohol (PVA) nanowebs: prolonged shelf-life and high
temperature stability of vanillin. Food Chem. 133 (3), 641–649.
Kayaci, F., Ertas, Y., Uyar, T., 2013a. Enhanced thermal stability of eugenol by
cyclodextrin inclusion complex encapsulated in electrospun polymeric
nanofibers. J. Agric. Food Chem. 61 (34), 8156–8165.
Kayaci, F., Umu, O.C., Tekinay, T., Uyar, T., 2013b. Antibacterial electrospun poly
(lactic acid) (PLA) nanofibrous webs incorporating triclosan/cyclodextrin
inclusion complexes. J. Agric. Food Chem. 61 (16), 3901–3908.
Kayaci, F., Sen, H.S., Durgun, E., Uyar, T., 2014. Functional electrospun polymeric
nanofibers incorporating geraniol-cyclodextrin inclusion complexes: high
thermal stability and enhanced durability of geraniol. Food Res. Int. 62, 424–431.
Kumar, S.U., Matai, I., Dubey, P., Bhushan, B., Sachdev, A., Gopinath, P., 2014.
Differentially cross-linkable core-shell nanofibers for tunable delivery of
anticancer drugs: synthesis, characterization and their anticancer efficacy. RSC
Adv. 4 (72), 38263–38272.
Llorens, E., Ibañez, H., Del Valle, L.J., Puiggalí, J., 2015. Biocompatibility and drug
release behavior of scaffolds prepared by coaxial electrospinning of poly
(butylene succinate) and polyethylene glycol. Mater. Sci. Eng. C 49, 472–484.
Massaro, M., Amorati, R., Cavallaro, G., Guernelli, S., Lazzara, G., Milioto, S., Noto, R.,
Poma, P., Riela, S., 2016. Direct chemical grafted curcumin on halloysite
nanotubes as dual-responsive prodrug for pharmacological applications.
Colloids Surf. B: Biointerfaces 140, 505–513.
Ramakrishna, S., Fujihara, K., Teo, W.E., Lim, T.C., Ma, Z., 2005. An Introduction to
Electrospinning and Nanofibers, vol. 90. World Scientific, Singapore.
Sampath, M., Lakra, R., Korrapati, P., Sengottuvelan, B., 2014. Curcumin loaded poly
(lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloids Surf.
B: Biointerfaces 117, 128–134.
Sedghi, R., Shaabani, A., 2016. Electrospun biocompatible core/shell polymer-free
core structure nanofibers with superior antimicrobial potency against multi
drug resistance organisms. Polymer 101, 151–157.Siviero, A., Gallo, E., Maggini, V., Gori, L., Mugelli, A., Firenzuoli, F., Vannacci, A., 2015.
Curcumin, a golden spice with a low bioavailability. J. Herb. Med. 5 (2), 57–70.
Sun, Z., Zussman, E., Yarin, A.L., Wendorff, J.H., Greiner, A., 2003. Compound core-
shell polymer nanofibers by co-electrospinning. Adv. Mater. 15 (22), 1929–1932.
Sun, X.Z., Williams, G.R., Hou, X.X., Zhu, L.M., 2013. Electrospun curcumin-loaded
fibers with potential biomedical applications. Carbohydr. Polym. 94 (1), 147–
153.
Sun, Y., Du, L., Liu, Y., Li, X., Li, M., Jin, Y., Qian, X., 2014. Transdermal delivery of the in
situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-
b-cyclodextrin for melanoma treatment. Int. J. Pharm. 469 (1), 31–39.
Suwantong, O., Opanasopit, P., Ruktanonchai, U., Supaphol, P., 2007. Electrospun
cellulose acetate fiber mats containing curcumin and release characteristic of
the herbal substance. Polymer 48 (26), 7546–7557.
Szejtli, J., 1998. Introduction and general overview of cyclodextrin chemistry. Chem.
Rev. 98 (5), 1743–1754.
Takahashi, A.I., Veiga, F.J.B., Ferraz, H.G., 2012. Literature review of cyclodextrins
inclusion complexes characterization – Part I: Phase solubility diagram,
dissolution and scanning electron microscopy. Int. J. Pharm. Sci. Rev. Res. 12 (1),
1–6.
Uyar, T., Hacaloglu, J., Besenbacher, F., 2009a. Electrospun polystyrene fibers
containing high temperature stable volatile fragrance/flavor facilitated by
cyclodextrin inclusion complexes. React. Funct. Polym. 69 (3), 145–150.
Uyar, T., Nur, Y., Hacaloglu, J., Besenbacher, F., 2009b. Electrospinning of functional
poly (methyl methacrylate) nanofibers containing cyclodextrin-menthol
inclusion complexes. Nanotechnology 20 (12), 125703.
Uyar, T., Hacaloglu, J., Besenbacher, F., 2011. Electrospun polyethylene oxide (PEO)
nanofibers containing cyclodextrin inclusion complex. J. Nanosci. Nanotechnol.
11 (5), 3949–3958.
Wang, X., Yu, D.G., Li, X.Y., Bligh, S.A., Williams, G.R., 2015. Electrospun medicated
shellac nanofibers for colon-targeted drug delivery. Int. J. Pharm. 490 (1), 384–
390.
Wendorff, J.H., Agarwal, S., Greiner, A., 2012. Electrospinning: Materials, Processing,
and Applications. John Wiley & Sons, Weinheim.
Yadav, V.R., Suresh, S., Devi, K., Yadav, S., 2009. Effect of cyclodextrin complexation of
curcumin on its solubility and antiangiogenic and anti-inflammatory activity in
rat colitis model. AAPS PharmSciTech. 10 (3), 752–762.
Yallapu, M.M., Nagesh, P.K.B., Jaggi, M., Chauhan, S.C., 2015. Therapeutic applications
of curcumin nanoformulations. AAPS J. 17 (6), 1341–1356.
